Henry Schein, Inc. (0L3C.L)
USD 63.62
(-2.71%)
USD 63.62
(-2.71%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.65 Billion USD | -4.7% |
| 2022 | 3.83 Billion USD | 4.32% |
| 2021 | 3.67 Billion USD | 30.48% |
| 2020 | 2.81 Billion USD | -8.95% |
| 2019 | 3.09 Billion USD | -14.02% |
| 2018 | 3.59 Billion USD | 5.77% |
| 2017 | 3.39 Billion USD | 5.11% |
| 2016 | 3.23 Billion USD | 7.36% |
| 2015 | 3.01 Billion USD | 3.47% |
| 2014 | 2.91 Billion USD | 9.61% |
| 2013 | 2.65 Billion USD | 5.92% |
| 2012 | 2.5 Billion USD | 3.7% |
| 2011 | 2.41 Billion USD | 11.39% |
| 2010 | 2.17 Billion USD | 13.25% |
| 2009 | 1.91 Billion USD | 1.71% |
| 2008 | 1.88 Billion USD | 9.68% |
| 2007 | 1.71 Billion USD | 16.1% |
| 2006 | 1.48 Billion USD | 12.39% |
| 2005 | 1.31 Billion USD | 22.35% |
| 2004 | 1.07 Billion USD | 16.09% |
| 2003 | 927.19 Million USD | 16.64% |
| 2002 | 794.9 Million USD | 13.67% |
| 2001 | 699.32 Million USD | 2.59% |
| 2000 | 681.66 Million USD | -6.2% |
| 1999 | 726.7 Million USD | 16.87% |
| 1998 | 621.8 Million USD | 33.66% |
| 1997 | 465.2 Million USD | 83.73% |
| 1996 | 253.2 Million USD | 28.79% |
| 1995 | 196.6 Million USD | 34.2% |
| 1994 | 146.5 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 955 Million USD | 0.42% |
| 2024 Q1 | 951 Million USD | 9.69% |
| 2023 Q1 | 966 Million USD | -3.3% |
| 2023 Q3 | 995 Million USD | 2.05% |
| 2023 Q4 | 867 Million USD | -12.86% |
| 2023 FY | 3.65 Billion USD | -4.7% |
| 2023 Q2 | 975 Million USD | 0.93% |
| 2022 Q1 | 973 Million USD | -0.66% |
| 2022 FY | 3.83 Billion USD | 4.32% |
| 2022 Q4 | 999 Million USD | 14.96% |
| 2022 Q3 | 869 Million USD | -3.44% |
| 2022 Q2 | 900 Million USD | -7.5% |
| 2021 Q4 | 979.5 Million USD | 7.38% |
| 2021 FY | 3.67 Billion USD | 30.48% |
| 2021 Q1 | 890.85 Million USD | 3.62% |
| 2021 Q2 | 889.75 Million USD | -0.12% |
| 2021 Q3 | 912.14 Million USD | 2.52% |
| 2020 Q2 | 454.29 Million USD | -39.11% |
| 2020 Q4 | 859.71 Million USD | 13.97% |
| 2020 Q3 | 754.29 Million USD | 66.04% |
| 2020 FY | 2.81 Billion USD | -8.95% |
| 2020 Q1 | 746.03 Million USD | -7.96% |
| 2019 Q4 | 810.59 Million USD | 6.49% |
| 2019 FY | 3.09 Billion USD | -14.02% |
| 2019 Q1 | 751.69 Million USD | -17.38% |
| 2019 Q2 | 767.43 Million USD | 2.09% |
| 2019 Q3 | 761.16 Million USD | -0.82% |
| 2018 Q4 | 909.86 Million USD | 2.4% |
| 2018 Q2 | 901.07 Million USD | 0.61% |
| 2018 Q1 | 895.59 Million USD | -0.6% |
| 2018 Q3 | 888.56 Million USD | -1.39% |
| 2018 FY | 3.59 Billion USD | 5.77% |
| 2017 FY | 3.39 Billion USD | 5.11% |
| 2017 Q4 | 900.95 Million USD | 7.76% |
| 2017 Q2 | 839.17 Million USD | 1.98% |
| 2017 Q3 | 836.05 Million USD | -0.37% |
| 2017 Q1 | 822.92 Million USD | -4.52% |
| 2016 Q3 | 789.49 Million USD | -1.72% |
| 2016 Q1 | 779.3 Million USD | -2.5% |
| 2016 Q2 | 803.31 Million USD | 3.08% |
| 2016 Q4 | 861.85 Million USD | 9.17% |
| 2016 FY | 3.23 Billion USD | 7.36% |
| 2015 Q3 | 748.9 Million USD | -0.24% |
| 2015 Q1 | 713.39 Million USD | -6.68% |
| 2015 Q2 | 750.67 Million USD | 5.23% |
| 2015 Q4 | 799.27 Million USD | 6.73% |
| 2015 FY | 3.01 Billion USD | 3.47% |
| 2014 FY | 2.91 Billion USD | 9.61% |
| 2014 Q1 | 696.71 Million USD | -0.4% |
| 2014 Q2 | 728.47 Million USD | 4.56% |
| 2014 Q3 | 721.66 Million USD | -0.93% |
| 2014 Q4 | 764.46 Million USD | 5.93% |
| 2013 Q3 | 639.64 Million USD | -4.51% |
| 2013 Q4 | 699.52 Million USD | 9.36% |
| 2013 Q2 | 669.85 Million USD | 3.53% |
| 2013 Q1 | 646.99 Million USD | -2.49% |
| 2013 FY | 2.65 Billion USD | 5.92% |
| 2012 Q3 | 609.04 Million USD | -2.46% |
| 2012 Q4 | 663.49 Million USD | 8.94% |
| 2012 Q1 | 610.57 Million USD | -6.44% |
| 2012 FY | 2.5 Billion USD | 3.7% |
| 2012 Q2 | 624.39 Million USD | 2.26% |
| 2011 Q3 | 587.42 Million USD | -4.05% |
| 2011 Q2 | 612.22 Million USD | 8.2% |
| 2011 Q4 | 652.58 Million USD | 11.09% |
| 2011 FY | 2.41 Billion USD | 11.39% |
| 2011 Q1 | 565.82 Million USD | -1.55% |
| 2010 Q2 | 545.64 Million USD | 6.36% |
| 2010 FY | 2.17 Billion USD | 13.25% |
| 2010 Q4 | 574.74 Million USD | 6.94% |
| 2010 Q3 | 537.45 Million USD | -1.5% |
| 2010 Q1 | 513.03 Million USD | -2.52% |
| 2009 FY | 1.91 Billion USD | 1.71% |
| 2009 Q1 | 441.01 Million USD | -5.43% |
| 2009 Q2 | 478.51 Million USD | 8.5% |
| 2009 Q3 | 476.26 Million USD | -0.47% |
| 2009 Q4 | 526.27 Million USD | 10.5% |
| 2008 Q4 | 466.3 Million USD | -2.56% |
| 2008 FY | 1.88 Billion USD | 9.68% |
| 2008 Q2 | 488.41 Million USD | 8.24% |
| 2008 Q1 | 451.23 Million USD | -6.8% |
| 2008 Q3 | 478.58 Million USD | -2.01% |
| 2007 Q3 | 429.33 Million USD | 3.76% |
| 2007 Q1 | 392.97 Million USD | -6.88% |
| 2007 Q4 | 484.13 Million USD | 12.76% |
| 2007 FY | 1.71 Billion USD | 16.1% |
| 2007 Q2 | 413.77 Million USD | 5.29% |
| 2006 Q3 | 361 Million USD | 0.43% |
| 2006 Q4 | 421.98 Million USD | 16.89% |
| 2006 Q2 | 359.46 Million USD | 6.47% |
| 2006 Q1 | 337.6 Million USD | -10.56% |
| 2006 FY | 1.48 Billion USD | 12.39% |
| 2005 Q1 | 306.18 Million USD | -4.27% |
| 2005 Q2 | 324.41 Million USD | 5.95% |
| 2005 Q3 | 316.73 Million USD | -2.37% |
| 2005 Q4 | 377.47 Million USD | 19.18% |
| 2005 FY | 1.31 Billion USD | 22.35% |
| 2004 Q2 | 251.71 Million USD | 9.05% |
| 2004 Q3 | 274.02 Million USD | 8.86% |
| 2004 FY | 1.07 Billion USD | 16.09% |
| 2004 Q4 | 319.83 Million USD | 16.72% |
| 2004 Q1 | 230.82 Million USD | -9.03% |
| 2003 Q2 | 220.52 Million USD | 9.49% |
| 2003 Q1 | 201.41 Million USD | -3.0% |
| 2003 Q3 | 251.5 Million USD | 14.04% |
| 2003 FY | 927.19 Million USD | 16.64% |
| 2003 Q4 | 253.74 Million USD | 0.89% |
| 2002 Q1 | 178.39 Million USD | -8.15% |
| 2002 FY | 794.9 Million USD | 13.67% |
| 2002 Q4 | 207.64 Million USD | -4.08% |
| 2002 Q3 | 216.47 Million USD | 12.51% |
| 2002 Q2 | 192.39 Million USD | 7.85% |
| 2001 FY | 699.32 Million USD | 2.59% |
| 2001 Q1 | 159.35 Million USD | 32.12% |
| 2001 Q2 | 166.89 Million USD | 4.73% |
| 2001 Q3 | 178.85 Million USD | 7.17% |
| 2001 Q4 | 194.21 Million USD | 8.59% |
| 2000 Q2 | 190.75 Million USD | 7.69% |
| 2000 FY | 681.66 Million USD | -6.2% |
| 2000 Q1 | 177.13 Million USD | -8.13% |
| 2000 Q3 | 193.16 Million USD | 1.26% |
| 2000 Q4 | 120.61 Million USD | -37.56% |
| 1999 Q1 | 170.4 Million USD | 1.55% |
| 1999 Q4 | 192.8 Million USD | 6.05% |
| 1999 Q3 | 181.8 Million USD | 0.0% |
| 1999 Q2 | 181.8 Million USD | 6.69% |
| 1999 FY | 726.7 Million USD | 16.87% |
| 1998 Q1 | 125.1 Million USD | -37.26% |
| 1998 Q2 | 137.9 Million USD | 10.23% |
| 1998 Q4 | 167.8 Million USD | 4.68% |
| 1998 Q3 | 160.3 Million USD | 16.24% |
| 1998 FY | 621.8 Million USD | 33.66% |
| 1997 Q2 | 81.3 Million USD | 9.86% |
| 1997 FY | 465.2 Million USD | 83.73% |
| 1997 Q1 | 74 Million USD | 1.79% |
| 1997 Q4 | 199.4 Million USD | 111.01% |
| 1997 Q3 | 94.5 Million USD | 16.24% |
| 1996 Q4 | 72.7 Million USD | 13.77% |
| 1996 FY | 253.2 Million USD | 28.79% |
| 1996 Q1 | 56.7 Million USD | -69.13% |
| 1996 Q2 | 59.7 Million USD | 5.29% |
| 1996 Q3 | 63.9 Million USD | 7.04% |
| 1995 Q2 | 139.8 Million USD | 2.79% |
| 1995 Q4 | 183.7 Million USD | 17.23% |
| 1995 FY | 196.6 Million USD | 34.2% |
| 1995 Q1 | 136 Million USD | -2.65% |
| 1995 Q3 | 156.7 Million USD | 12.09% |
| 1994 Q1 | 108.4 Million USD | 0.0% |
| 1994 Q2 | 115.8 Million USD | 6.83% |
| 1994 FY | 146.5 Million USD | 0.0% |
| 1994 Q4 | 139.7 Million USD | 13.85% |
| 1994 Q3 | 122.7 Million USD | 5.96% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -1709.71% |
| Accuray Incorporated | 143.12 Million USD | -2450.988% |
| Align Technology, Inc. | 2.72 Billion USD | -34.22% |
| Elevance Health Inc. | 47.01 Billion USD | 92.234% |
| AxoGen, Inc. | 127.87 Million USD | -2755.154% |
| Boston Scientific Corporation | 9.84 Billion USD | 62.93% |
| CVS Health Corporation | 54.43 Billion USD | 93.292% |
| Cardinal Health, Inc. | 7.41 Billion USD | 50.755% |
| Centene Corporation | 153.99 Billion USD | 97.629% |
| DaVita Inc. | 3.82 Billion USD | 4.435% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 93.37% |
| Hologic, Inc. | 2.23 Billion USD | -63.151% |
| Humana Inc. | 106.44 Billion USD | 96.57% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -66.715% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | -8.502% |
| Masimo Corporation | 1 Billion USD | -263.827% |
| McKesson Corporation | 12.58 Billion USD | 70.987% |
| Patterson Companies, Inc. | 1.38 Billion USD | -164.519% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | -23.303% |
| ResMed Inc. | 2.6 Billion USD | -39.95% |
| Teladoc Health, Inc. | 1.84 Billion USD | -98.167% |
| Universal Health Services, Inc. | 1.17 Billion USD | -210.623% |
| Veeva Systems Inc. | 1.68 Billion USD | -116.499% |
| Baxter International Inc. | 4.97 Billion USD | 26.613% |
| Becton, Dickinson and Company | 8.82 Billion USD | 58.62% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 22.804% |
| Danaher Corporation | 14.12 Billion USD | 74.16% |
| Stryker Corporation | 13.05 Billion USD | 72.04% |
| Medtronic plc | 21.27 Billion USD | 82.837% |